🇺🇸 FDA
Pipeline program

FX006

FX006-2018-016

Phase 2 small_molecule terminated

Quick answer

FX006 for Osteoarthritis of the Shoulder is a Phase 2 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Osteoarthritis of the Shoulder
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials